Our first guest is Our guest today is Dr. William Scott Magill the founder and executive Director of Veterans in Defense of Liberty (ViDoL) . After 30 years of practice, including some 9000 deliveries, Dr. Magill closed his doors in order to devote all of his efforts to the survival of the U.S. Constitution. Dr. Magill stated at that time, “If we can establish, for the first time in American history, that vehicle for American veterans to fulfill their oath, which did not vanish when we took off our uniforms for the last time, this will be a full time effort.”
Dr. William Scott Magill, Executive Director of “Veterans In Defense of Liberty” (VIDOL) as they discuss the Charter of VIDOL and how Veterans can join and be part of this very important organization. www.vidolamerica.org Check out Dr. McGill interview at https://www.youtube.com/watch?v=q-fozmiWr9U
Our second guests will discuss the Important Treatment for Most Deadly Type of Skin Cancer FDA-approved combination treatment targets BRAF-mutant metastatic melanoma. Metastatic melanoma is the most serious and life-threatening type of skin cancer and is associated with low survival rates. There are a variety of gene mutations that can lead to metastatic melanoma, but the most common is BRAF. Despite recent advancements, many patients with BRAF-mutant metastatic melanoma still face significant challenges managing their disease, and there remains a substantial need for treatments that delay disease progression and impact survival.
Our guest today are Dr. Anna Pavlick, D.O. – Medical Oncologist, NYU Langone. Dr. Pavlick is the co-director of the melanoma program at the NYU Perlmutter Cancer Center. She is also a professor of medicine and dermatology at NYU Langone Medical Center. Dr. Pavlick has contributed to multiple studies in melanoma and published in peer-reviewed journals. She completed her fellowship in Hematology/Oncology at Memorial Sloan-Kettering Cancer Center, is board certified in medical oncology and received her Doctor of Osteopathic Medicine from the University of Medicine & Dentistry of New Jersey and Master of Business Administration from Columbia Business School.
Gary Larrabee – Patient and Clinical Trial Participant, Mr. Larrabee is a former sports journalist and currently an institutional historian focused on golf history. He has three children and has been with his partner, Anne, for 23 years. Following an initial melanoma diagnosis 10 years ago, he had no evidence of disease for five years until he was diagnosed with Stage IV melanoma in 2013. A molecular test revealed that he had a BRAF V600 gene mutation and his doctor recommended he enroll in the COLUMBUS
Our last guest is Jeff Zwiefel – Chief Operating Officer of Life Time, Inc., he will discuss the opening of 141 Clubs of Life Time, The Premier Healthy Lifestyle Brand that they opened om Jan 1, 2019 to help people overcome Hurdles and achieve their 2019 goals.
For most, the new year brings a time to reset and create new goals for ourselves. Whether the goals be related to health, wellness, or picking up a new hobby, statistics show that more than 80 percent of New Year resolutions are unattainable due lack of time, willpower, or motivation. It is much easier to be successful with our New Year Resolutions if we know that we have a support system behind us. Life Time is ready to help jump-start new year resolutions with their Commitment Day which was on January 1, a day where people of all ages and abilities were encouraged to kick-off the year in a healthy, happy way. Unique and fun group fitness, indoor cycle and yoga classes for all levels and abilities will be available throughout the day. Participating centers also hosted the Commitment Day 5K, an outdoor run, which was also held on January 1, 2019.
For more information please visit: https://www.lifetime.life/